125 related articles for article (PubMed ID: 38773600)
1. Thyroid papillary carcinoma combined with primary follicular lymphoma: a case report.
Xu T; Wu L; Ye H; Luo S; Wang J
Diagn Pathol; 2024 May; 19(1):69. PubMed ID: 38773600
[TBL] [Abstract][Full Text] [Related]
2. Combined effect of Hashimoto's thyroiditis and BRAF(V600E) mutation status on aggressiveness in papillary thyroid cancer.
Kim SJ; Myong JP; Jee HG; Chai YJ; Choi JY; Min HS; Lee KE; Youn YK
Head Neck; 2016 Jan; 38(1):95-101. PubMed ID: 25213729
[TBL] [Abstract][Full Text] [Related]
3. EZH2 upregulation by ERα induces proliferation and migration of papillary thyroid carcinoma.
Xue L; Yan H; Chen Y; Zhang Q; Xie X; Ding X; Wang X; Qian Z; Xiao F; Song Z; Wu Y; Peng Y; Xu H
BMC Cancer; 2019 Nov; 19(1):1094. PubMed ID: 31718595
[TBL] [Abstract][Full Text] [Related]
4. Co-occurrence of papillary thyroid carcinoma and primary lymphoma of the thyroid in a patient with long-standing Hashimoto's thyroiditis.
Cheng V; Brainard J; Nasr C
Thyroid; 2012 Jun; 22(6):647-50. PubMed ID: 22568399
[TBL] [Abstract][Full Text] [Related]
5. Coexistence of Papillary Thyroid Carcinoma With Thyroid MALT Lymphoma in a Patient With Hashimoto's Thyroiditis: A Clinical Case Report.
Shen G; Ji T; Hu S; Liu B; Kuang A
Medicine (Baltimore); 2015 Dec; 94(52):e2403. PubMed ID: 26717396
[TBL] [Abstract][Full Text] [Related]
6. [Differential protein expressions in papillary thyroid carcinoma patients with or without Hashimoto's thyroiditis].
Lu HZ; Zhang N; Liu W; Zhu XY; Qi D; Wang Y; Liu XY; Li ZJ
Zhonghua Zhong Liu Za Zhi; 2020 Jun; 42(6):463-468. PubMed ID: 32575941
[No Abstract] [Full Text] [Related]
7. Correlation Between the Clinicopathological Features of Papillary Thyroid Carcinoma Complicated with Hashimoto's Thyroiditis, BRAF V600E Gene Mutation, and RET Gene Rearrangement.
Xie M; Xu ZX; Dai M; Zhu YY
J Coll Physicians Surg Pak; 2024 Apr; 34(4):445-450. PubMed ID: 38576288
[TBL] [Abstract][Full Text] [Related]
8. Solid papillary thyroid carcinoma with Hashimoto's thyroiditis: description of a further case with challenging cytological features.
Fulciniti F; Barizzi J; Trimboli P; Giovanella L
BMJ Case Rep; 2019 Jan; 12(1):. PubMed ID: 30659000
[TBL] [Abstract][Full Text] [Related]
9. Integrating BRAF
Zhang Z; Zhang X; Yin Y; Zhao S; Wang K; Shang M; Chen B; Wu X
BMC Cancer; 2022 Apr; 22(1):461. PubMed ID: 35473554
[TBL] [Abstract][Full Text] [Related]
10. Coexistence of Hashimoto's thyroiditis and papillary thyroid carcinoma revisited in thyroidology, an experience from an endemic region: fad or future?
Cinar I; Sengul I
Rev Assoc Med Bras (1992); 2024; 70(4):e20231380. PubMed ID: 38747877
[TBL] [Abstract][Full Text] [Related]
11. Well-differentiated thyroid carcinoma with concomitant Hashimoto's thyroiditis present with less aggressive clinical stage and low recurrence.
Huang BY; Hseuh C; Chao TC; Lin KJ; Lin JD
Endocr Pathol; 2011 Sep; 22(3):144-9. PubMed ID: 21647844
[TBL] [Abstract][Full Text] [Related]
12. Coexistence of diffuse large B-cell lymphoma and papillary thyroid carcinoma in a patient affected by Hashimoto's thyroiditis.
Trovato M; Giuffrida G; Seminara A; Fogliani S; Cavallari V; Ruggeri RM; Campennì A
Arch Endocrinol Metab; 2017 Dec; 61(6):643-646. PubMed ID: 29412392
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathological features and immunohistochemical utility of NTRK-, ALK-, and ROS1-rearranged papillary thyroid carcinomas and anaplastic thyroid carcinomas.
Nozaki Y; Yamamoto H; Iwasaki T; Sato M; Jiromaru R; Hongo T; Yasumatsu R; Oda Y
Hum Pathol; 2020 Dec; 106():82-92. PubMed ID: 32980422
[TBL] [Abstract][Full Text] [Related]
14. Association between diffuse lymphocytic infiltration and papillary thyroid cancer aggressiveness according to the presence of thyroid peroxidase antibody and BRAF
Lee YK; Park KH; Park SH; Kim KJ; Shin DY; Nam KH; Chung WY; Lee EJ
Head Neck; 2018 Oct; 40(10):2271-2279. PubMed ID: 29935011
[TBL] [Abstract][Full Text] [Related]
15. Alterations of regulatory factors and DNA methylation pattern in thyroid cancer.
Iancu IV; Botezatu A; Plesa A; Huica I; Fudulu A; Albulescu A; Bostan M; Mihaila M; Grancea C; Manda DA; Dobrescu R; Vladoiu SV; Anton G; Badiu CV
Cancer Biomark; 2020; 28(2):255-268. PubMed ID: 32390600
[TBL] [Abstract][Full Text] [Related]
16. Association between Hashimoto's thyroiditis and papillary thyroid carcinoma: a retrospective analysis of 305 patients.
Graceffa G; Patrone R; Vieni S; Campanella S; Calamia S; Laise I; Conzo G; Latteri M; Cipolla C
BMC Endocr Disord; 2019 May; 19(Suppl 1):26. PubMed ID: 31142293
[TBL] [Abstract][Full Text] [Related]
17. Hashimoto's thyroiditis, nodular goiter or follicular adenoma combined with papillary thyroid carcinoma play protective role in patients.
Ma H; Li L; Li K; Wang T; Zhang Y; Zhang C; Xu Y; Wu X; Yu J; Wang H; Xiang B; Zhang R; Wang W
Neoplasma; 2018 Mar; 65(3):436-440. PubMed ID: 29788738
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathological characterization and prognostic implication of FOXP3 and CK19 expression in papillary thyroid carcinoma and concomitant Hashimoto's thyroiditis.
Mohamed SY; Ibrahim TR; Elbasateeny SS; Abdelaziz LA; Farouk S; Yassin MA; Embaby A
Sci Rep; 2020 Jun; 10(1):10651. PubMed ID: 32606302
[TBL] [Abstract][Full Text] [Related]
19. Hashimoto's thyroiditis with papillary thyroid carcinoma (PTC)-like nuclear alterations express molecular markers of PTC.
Prasad ML; Huang Y; Pellegata NS; de la Chapelle A; Kloos RT
Histopathology; 2004 Jul; 45(1):39-46. PubMed ID: 15228442
[TBL] [Abstract][Full Text] [Related]
20. Primary squamous cell carcinoma of the thyroid associated with papillary thyroid carcinoma and Hashimoto's thyroiditis.
Kallel S; Kallel R; Ayadi S; Ghorbel A
Eur Ann Otorhinolaryngol Head Neck Dis; 2018 Aug; 135(4):291-293. PubMed ID: 29914738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
